International collaboration tackles Ross River virus

7 Dec 2015

An international collaboration to discover and develop therapeutic drugs is set to find new treatments for Ross River virus.

The mosquito-borne virus is widespread across Australia and the South Pacific, and is responsible for the debilitating Ross River fever that strikes about 5000 Australians a year.

The collaboration involves Emory University’s Drug Innovation Ventures at Emory, LLC (DRIVE) and University of Queensland (UQ) commercialisation company UniQuest, through the Queensland Emory Drug Discovery Initiative (QEDDI).

QEDDI, DRIVE and the Emory Institute of Drug Development (EIDD) will provide medicinal chemistry expertise, with Ross River virus expertise from Professor Paul Young and colleagues in the UQ School of Chemistry and Molecular Biosciences.

Read the full story on UQ News.